R. Sastry, E. Williams, Robert M. Koffie, K. Fehnel, L. Wirth, B. Nahed
{"title":"癌症髓样癌脑转移1例报告及文献复习","authors":"R. Sastry, E. Williams, Robert M. Koffie, K. Fehnel, L. Wirth, B. Nahed","doi":"10.2217/IJE-2017-0024","DOIUrl":null,"url":null,"abstract":"Medullary thyroid cancer rarely metastasizes to the brain. Presentation and optimal treatment approaches vary widely. We present a 53-year-old male, diagnosed with medullary thyroid cancer 21 years prior, who was presented with at least seven metastases in his brain. He underwent two craniotomies for two large, hemorrhagic metastases followed by whole brain radiation therapy. Tumor genotyping revealed a somatic C634R mutation in the RET proto-oncogene. Subsequently, he was started on multikinase inhibitor therapy. He ultimately passed away 10 months after his surgery. Complete resection may be a reasonable approach for patients with one or more cerebral or cerebellar metastases when feasible. Further analysis is necessary to understand the specific mutations that predispose medullary thyroid cancer to central nervous system metastasis.","PeriodicalId":42691,"journal":{"name":"International Journal of Endocrine Oncology","volume":null,"pages":null},"PeriodicalIF":1.2000,"publicationDate":"2018-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.2217/IJE-2017-0024","citationCount":"2","resultStr":"{\"title\":\"Metastatic medullary thyroid cancer to the brain: a case report and review of the literature\",\"authors\":\"R. Sastry, E. Williams, Robert M. Koffie, K. Fehnel, L. Wirth, B. Nahed\",\"doi\":\"10.2217/IJE-2017-0024\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Medullary thyroid cancer rarely metastasizes to the brain. Presentation and optimal treatment approaches vary widely. We present a 53-year-old male, diagnosed with medullary thyroid cancer 21 years prior, who was presented with at least seven metastases in his brain. He underwent two craniotomies for two large, hemorrhagic metastases followed by whole brain radiation therapy. Tumor genotyping revealed a somatic C634R mutation in the RET proto-oncogene. Subsequently, he was started on multikinase inhibitor therapy. He ultimately passed away 10 months after his surgery. Complete resection may be a reasonable approach for patients with one or more cerebral or cerebellar metastases when feasible. Further analysis is necessary to understand the specific mutations that predispose medullary thyroid cancer to central nervous system metastasis.\",\"PeriodicalId\":42691,\"journal\":{\"name\":\"International Journal of Endocrine Oncology\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":1.2000,\"publicationDate\":\"2018-08-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://sci-hub-pdf.com/10.2217/IJE-2017-0024\",\"citationCount\":\"2\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"International Journal of Endocrine Oncology\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.2217/IJE-2017-0024\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Journal of Endocrine Oncology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.2217/IJE-2017-0024","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Metastatic medullary thyroid cancer to the brain: a case report and review of the literature
Medullary thyroid cancer rarely metastasizes to the brain. Presentation and optimal treatment approaches vary widely. We present a 53-year-old male, diagnosed with medullary thyroid cancer 21 years prior, who was presented with at least seven metastases in his brain. He underwent two craniotomies for two large, hemorrhagic metastases followed by whole brain radiation therapy. Tumor genotyping revealed a somatic C634R mutation in the RET proto-oncogene. Subsequently, he was started on multikinase inhibitor therapy. He ultimately passed away 10 months after his surgery. Complete resection may be a reasonable approach for patients with one or more cerebral or cerebellar metastases when feasible. Further analysis is necessary to understand the specific mutations that predispose medullary thyroid cancer to central nervous system metastasis.
期刊介绍:
International Journal of Endocrine Oncology is a quarterly, peer-reviewed journal that helps the clinician to keep up to date with best practice in this fast-moving field. The journal highlights significant advances in basic and translational research, and places them in context for future therapy. The journal presents the latest research findings in diagnosis and management of endocrine cancer, together with authoritative reviews, cutting-edge editorials and perspectives that highlight hot topics and controversy in the field. Independent drug evaluations assess newly approved medications and their role in clinical practice. The journal welcomes the unsolicited submission of article proposals and original research manuscripts.